CA2382769A1 - 42 proteines humaines secretees - Google Patents
42 proteines humaines secretees Download PDFInfo
- Publication number
- CA2382769A1 CA2382769A1 CA002382769A CA2382769A CA2382769A1 CA 2382769 A1 CA2382769 A1 CA 2382769A1 CA 002382769 A CA002382769 A CA 002382769A CA 2382769 A CA2382769 A CA 2382769A CA 2382769 A1 CA2382769 A1 CA 2382769A1
- Authority
- CA
- Canada
- Prior art keywords
- seq
- polypeptide
- sequence
- human
- antibodies
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/04—Amoebicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Neurology (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Virology (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
Abstract
L'invention concerne de nouvelles protéines humaines sécrétées ainsi que des acides nucléiques isolés contenant les régions codantes des gènes codant pour ces protéines. Elle concerne également des vecteurs, des cellules hôtes, des anticorps et des méthodes de recombinaison pour la production de protéines humaines sécrétées. Elle se rapporte en outre à des méthodes diagnostiques et thérapeutiques permettant de diagnostiquer et de traiter les maladies, troubles et/ou états pathologiques liés à ces nouvelles protéines humaines sécrétées.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13857399P | 1999-06-11 | 1999-06-11 | |
US60/138,573 | 1999-06-11 | ||
US17485100P | 2000-01-07 | 2000-01-07 | |
US60/174,851 | 2000-01-07 | ||
PCT/US2000/014929 WO2000077173A1 (fr) | 1999-06-11 | 2000-06-01 | 42 proteines humaines secretees |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2382769A1 true CA2382769A1 (fr) | 2000-12-21 |
Family
ID=26836323
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002382769A Abandoned CA2382769A1 (fr) | 1999-06-11 | 2000-06-01 | 42 proteines humaines secretees |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1187908A4 (fr) |
JP (1) | JP2003502031A (fr) |
AU (1) | AU5174600A (fr) |
CA (1) | CA2382769A1 (fr) |
WO (1) | WO2000077173A1 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1158049A1 (fr) * | 2000-05-26 | 2001-11-28 | Aeomica, INC. | Gène resemblant à la myosine exprimé dans le coeur et le muscle |
GB2380197A (en) * | 2000-05-26 | 2003-04-02 | Aeomica Inc | Myosin-like gene expressed in human heart and muscle |
WO2001092524A2 (fr) * | 2000-05-26 | 2001-12-06 | Aeomica, Inc. | Gene du type myosine exprime dans le coeur et les muscles humains |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2277266A1 (fr) * | 1997-01-31 | 1998-08-06 | Genentech, Inc. | O-fucosyltransferase |
-
2000
- 2000-06-01 JP JP2001503618A patent/JP2003502031A/ja not_active Withdrawn
- 2000-06-01 WO PCT/US2000/014929 patent/WO2000077173A1/fr not_active Application Discontinuation
- 2000-06-01 CA CA002382769A patent/CA2382769A1/fr not_active Abandoned
- 2000-06-01 AU AU51746/00A patent/AU5174600A/en not_active Abandoned
- 2000-06-01 EP EP00936429A patent/EP1187908A4/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2000077173A1 (fr) | 2000-12-21 |
EP1187908A1 (fr) | 2002-03-20 |
EP1187908A4 (fr) | 2003-09-10 |
AU5174600A (en) | 2001-01-02 |
JP2003502031A (ja) | 2003-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2368068A1 (fr) | 27 proteines humaines secretees | |
CA2385475A1 (fr) | 18 proteines secretees humaines | |
CA2382185A1 (fr) | 48 proteines secretees humaines | |
CA2370489A1 (fr) | 49 proteines humaines secretees | |
CA2368927A1 (fr) | Quarante-cinq proteines humaines secretees | |
CA2364209A1 (fr) | 49 proteines secretees humaines | |
CA2387696A1 (fr) | 48 proteines humaines secretees | |
CA2364630A1 (fr) | 50 proteines humaines secretees | |
CA2365223A1 (fr) | Proteines humaines secretees (46) | |
CA2368281A1 (fr) | 50 proteines humaines secretees | |
CA2368467A1 (fr) | 50 proteines humaines secretees | |
CA2391364A1 (fr) | 47 proteines humaines secretees | |
CA2365522A1 (fr) | 48 proteines secretees humaines | |
CA2364635A1 (fr) | 47 proteines humaines secretees | |
CA2368302A1 (fr) | 49 proteines secretees par un etre humain | |
CA2370441A1 (fr) | 50 proteines humaines secretees | |
CA2365247A1 (fr) | Proteines humaines secretees (49) | |
CA2382769A1 (fr) | 42 proteines humaines secretees | |
CA2368442A1 (fr) | 48 proteines humaines secretees | |
CA2368719A1 (fr) | Cinquante proteines humaines secretees | |
CA2371172A1 (fr) | 50 proteines humaines secretees | |
CA2364650A1 (fr) | Proteines humaines secretees (50) | |
CA2368374A1 (fr) | 47 proteines humaines secretees | |
CA2368916A1 (fr) | 49 proteines humaines secretees | |
CA2367620A1 (fr) | Proteines humaines secretees (47) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |